18.900
+0,00%
2026-10-16
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -7.4% | +14.1% | 2 / 3 | -4.7% | +0.85 pp | -0.37 pp | +18.0% | 0.23 | 6.99 | 85,9 | −4,7% | 10,8 | −7,4% | 6.99 | 7.68 | −9,0% |
| Pts | 0 | 0 | 8 | 0 | 8 | 4 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 18.900 (close price on 2026-10-16)EPS (TTM): 2.705
Financial charts
1.Revenue & growth
VND bn86,4Q2/26
1.Revenue & growth
VND bn86,4Q2/26
2.Profit & growth
VND bn10,9Q2/26
3.Profit mix (Penman)
VND bn54,7Q2/26
4.Margins & cost structure
%26.3%Q2/26
5.Returns & cash cycle
% · days28.7%Q2/26
6.Earnings quality & cash
VND bn83,7Q2/26
7.Asset structure
VND bn383Q2/26
8.Funding & debt health
VND bn · times383Q2/26
9.Revenue backlog
VND bn0,09Q2/26
10.Valuation
times · %7,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %677Q2/26
Adjusted EPS growth, latest quarter
-6.6%
Average adjusted EPS growth, 3 quarters
14.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26